BSE Live
Dec 27, 11:22Prev. Close
2.30
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Standard Medical Pharmaceuticals (in Rs. Cr.) | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.07 | -0.25 | -0.12 | -0.12 | 2.10 | |
| Diluted EPS (Rs.) | -0.07 | -0.25 | -0.12 | -0.12 | 2.10 | |
| Cash EPS (Rs.) | -0.06 | -0.25 | -0.12 | -0.11 | 2.11 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -14.78 | -14.72 | -14.46 | -14.34 | -14.22 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -14.78 | -14.72 | -14.46 | -14.34 | -14.22 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | -0.06 | -0.10 | -0.12 | -0.11 | 2.11 | |
| PBIT/Share (Rs.) | -0.07 | -0.11 | -0.12 | -0.12 | 2.10 | |
| PBT/Share (Rs.) | -0.07 | -0.11 | -0.12 | -0.12 | 2.10 | |
| Net Profit/Share (Rs.) | -0.07 | -0.25 | -0.12 | -0.12 | 2.10 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | 0.45 | 1.72 | 0.84 | 0.80 | -14.74 | |
| Return on Capital Employed (%) | -4.63 | -14.95 | 1.79 | 1.58 | -28.30 | |
| Return on Assets (%) | -2.59 | -9.69 | -4.04 | -4.36 | 78.92 | |
| Total Debt/Equity (X) | -1.13 | -1.13 | -0.53 | -0.49 | -0.48 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.04 | 0.05 | 0.04 | 0.01 | 0.01 | |
| Quick Ratio (X) | 0.04 | 0.05 | 0.04 | 0.01 | 0.01 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |